Phibro Animal Health (PAHC) Prepaid Assets (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Prepaid Assets came in at $55.4 million in Q1 2026, down 7.34% year-on-year from $59.8 million in Q1 2025, and up 1.68% quarter-over-quarter from $54.5 million in Q4 2025.
Phibro Animal Health (PAHC) Prepaid Assets (2013 - 2026) Analysis & Trends
Phibro Animal Health's Prepaid Assets history runs 14 years deep, the most recent figure standing at $55.4 million for Q1 2026.
- On a quarterly basis, Prepaid Assets fell 7.34% year-over-year to $55.4 million in Q1 2026; TTM through Mar 2026 was $55.4 million, a 7.34% decrease from a year earlier, with the FY2025 full-year figure at $61.2 million, up 19.87% from the prior year.
- Prepaid Assets improved to $55.4 million in Q1 2026 per PAHC's latest filing, from $54.5 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $64.9 million in Q3 2023 and bottomed at $47.2 million in Q1 2022.
- The 5-year median for Prepaid Assets is $59.8 million (2025), against an average of $57.2 million.
- Across the five-year window, Prepaid Assets surged 56.74% in 2022 and declined 26.65% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $62.5 million in 2022, then declined by 9.07% to $56.8 million in 2023, then grew by 5.78% to $60.1 million in 2024, then fell by 9.34% to $54.5 million in 2025, then increased by 1.68% to $55.4 million in 2026.
- Per Business Quant, the three latest PAHC Prepaid Assets figures stand at $55.4 million (Q1 2026), $54.5 million (Q4 2025), and $60.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.37 Mn |
| Dec 31, 2025 | 54.46 Mn |
| Sep 30, 2025 | 60.86 Mn |
| Jun 30, 2025 | 61.16 Mn |
| Mar 31, 2025 | 59.76 Mn |
| Dec 31, 2024 | 60.07 Mn |
| Sep 30, 2024 | 47.60 Mn |
| Jun 30, 2024 | 51.02 Mn |
| Mar 31, 2024 | 55.06 Mn |
| Dec 31, 2023 | 56.79 Mn |
| Sep 30, 2023 | 64.89 Mn |
| Jun 30, 2023 | 63.39 Mn |
| Mar 31, 2023 | 62.67 Mn |
| Dec 31, 2022 | 62.45 Mn |
| Sep 30, 2022 | 60.23 Mn |
| Jun 30, 2022 | 49.29 Mn |
| Mar 31, 2022 | 47.16 Mn |
| Dec 31, 2021 | 39.85 Mn |
| Sep 30, 2021 | 39.50 Mn |
| Jun 30, 2021 | 42.53 Mn |